Monashee Investment Management LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Monashee Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$8.16 - $15.1 $2.16 Million - $3.99 Million	-264,111 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$11.2 - $16.97 $401,956 - $609,036	-35,889 Reduced 11.96%	264,111 $3.89 Million
Q4 2021 Feb 07, 2022	BUY	$12.36 - $18.28 $2.16 Million - $3.2 Million	175,000 Added 140.0%	300,000 $3.97 Million
Q3 2021 Nov 09, 2021	BUY	$17.11 - $24.49 $2.14 Million - $3.06 Million	125,000 New	125,000 $2.18 Million
Q4 2018 Feb 12, 2019	SELL	$16.21 - $24.06 $1.3 Million - $1.92 Million	-80,000 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$8.0 - $22.11 $640,000 - $1.77 Million	80,000 New	80,000 $1.77 Million

135

52M

551K

98K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $240M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.